Published in Vaccine Weekly, December 29th, 2010
The team found that the absence of the function of a protein called NLRP3 can result in a four-fold increase in a tumor's response to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.